Misplaced Pages

Edobacomab

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is the current revision of this page, as edited by Entranced98 (talk | contribs) at 13:13, 30 May 2023 (Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound"). The present address (URL) is a permanent link to this version.

Revision as of 13:13, 30 May 2023 by Entranced98 (talk | contribs) (Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound")(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Monoclonal antibody Pharmaceutical compound
Edobacomab
Monoclonal antibody
TypeWhole antibody
SourceMouse
Targetendotoxin
Clinical data
Routes of
administration
Intravenous infusion
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
  (what is this?)  (verify)

Edobacomab, codenamed E5, is a mouse monoclonal antibody that was investigated as a possible treatment for sepsis caused by Gram-negative bacterial infections.

Further reading

Monoclonal antibodies for infectious disease and toxins
Fungal
Human
Viral
Human
Chimeric
Humanized
Bacterial
Human
Mouse
Chimeric
Humanized
Toxin
Human
Chimeric
Humanized
Stub icon

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

Categories: